Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | 226,00 € | 251,80 € | 11,42 % |
| Neurocrine Bioscience | 33 | 0 | 2 | 0 | 128,00 € | 140,87 € | 10,05 % |
| Acadia Pharmaceuticals | 30 | 1 | 2 | 0 | 14,93 € | 31,00 € | 107,66 % |
| Iovance Biotherapeutics Inc. | 22 | 2 | 1 | 0 | 6,88 € | 26,25 € | 281,49 % |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 2 | 0 | 37,40 € | 85,51 € | 128,64 % |
| United Therapeutics | 21 | 0 | 3 | 0 | 282,20 € | 288,66 € | 2,29 % |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 0 | 0 | 42,23 € | 56,72 € | 34,32 % |
| Halozyme Therapeutics Inc. | 20 | 0 | 5 | 0 | 49,00 € | 52,75 € | 7,65 % |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 4 | 0 | 23,26 € | 54,74 € | 135,36 % |
| Exelixis Inc. | 18 | 0 | 0 | 0 | 20,34 € | 26,01 € | 27,86 % |
| PTC Therapeutics Inc. | 16 | 9 | 2 | 1 | 27,20 € | 41,81 € | 53,73 % |
| Xencor Inc. | 14 | 1 | 4 | 0 | 16,80 € | 31,70 € | 88,67 % |
| Medpace Holdings Inc | 12 | 0 | 1 | 0 | 373,20 € | 419,82 € | 12,49 % |
| Charles River Labs Intl | 11 | 0 | 1 | 0 | 186,45 € | 249,59 € | 33,87 % |
| Agios Pharmaceuticals Inc. | 8 | 1 | 2 | 1 | 39,00 € | 43,87 € | 12,48 % |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | 9,15 € | 17,64 € | 92,76 % |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | 1,19 € | 2,40 € | 101,85 % |
| Emergent Biosolutions Inc. | 4 | 3 | 2 | 0 | 6,97 € | 7,45 € | 6,96 % |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | 100,85 € | - | - |
| Catalent Inc. | 1 | 0 | 0 | 0 | 52,47 € | 55,00 € | 4,82 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 15,64 € | - | - |